Qiang Fu
Concepts (352)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoblasts | 9 | 2024 | 450 | 2.070 |
Why?
| Osteoclasts | 11 | 2024 | 425 | 1.830 |
Why?
| Bone Resorption | 7 | 2024 | 304 | 1.670 |
Why?
| Somatostatin | 4 | 2014 | 30 | 1.630 |
Why?
| RANK Ligand | 13 | 2024 | 179 | 1.520 |
Why?
| Carrier Proteins | 7 | 2015 | 304 | 1.480 |
Why?
| Vitamin E | 6 | 2020 | 81 | 1.320 |
Why?
| Chromans | 5 | 2014 | 37 | 1.210 |
Why?
| Radiation-Protective Agents | 7 | 2020 | 74 | 1.180 |
Why?
| Cell-Derived Microparticles | 2 | 2017 | 20 | 1.080 |
Why?
| Recombinant Fusion Proteins | 4 | 2014 | 181 | 1.080 |
Why?
| Animals | 43 | 2024 | 13187 | 1.050 |
Why?
| Mice | 33 | 2024 | 5739 | 1.040 |
Why?
| Serum Albumin | 3 | 2014 | 58 | 1.020 |
Why?
| Osteocytes | 3 | 2024 | 207 | 0.980 |
Why?
| Atenolol | 1 | 2024 | 14 | 0.980 |
Why?
| Theca Cells | 1 | 2024 | 1 | 0.980 |
Why?
| Primary Ovarian Insufficiency | 1 | 2024 | 4 | 0.980 |
Why?
| Biological Availability | 2 | 2024 | 122 | 0.970 |
Why?
| Mitochondrial Dynamics | 1 | 2024 | 18 | 0.970 |
Why?
| Tissue Scaffolds | 1 | 2024 | 33 | 0.960 |
Why?
| Solubility | 1 | 2024 | 69 | 0.960 |
Why?
| Pichia | 3 | 2014 | 8 | 0.960 |
Why?
| Urethra | 1 | 2024 | 89 | 0.950 |
Why?
| Tissue Engineering | 1 | 2024 | 64 | 0.930 |
Why?
| Rats, Sprague-Dawley | 3 | 2024 | 1597 | 0.770 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 138 | 0.720 |
Why?
| Mice, Inbred C57BL | 13 | 2024 | 1816 | 0.650 |
Why?
| Whole-Body Irradiation | 7 | 2021 | 131 | 0.590 |
Why?
| Imipramine | 1 | 2017 | 13 | 0.590 |
Why?
| Cell Differentiation | 4 | 2024 | 651 | 0.580 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2017 | 32 | 0.570 |
Why?
| Radiation Injuries, Experimental | 3 | 2019 | 81 | 0.550 |
Why?
| Intestinal Mucosa | 5 | 2021 | 225 | 0.550 |
Why?
| Bone Density Conservation Agents | 1 | 2017 | 77 | 0.550 |
Why?
| Parathyroid Hormone | 7 | 2017 | 147 | 0.530 |
Why?
| Bone Remodeling | 2 | 2015 | 150 | 0.530 |
Why?
| Subcellular Fractions | 1 | 2015 | 34 | 0.520 |
Why?
| Intestines | 6 | 2021 | 176 | 0.510 |
Why?
| Membrane Glycoproteins | 4 | 2006 | 240 | 0.510 |
Why?
| Cell Line | 7 | 2017 | 1000 | 0.510 |
Why?
| Cell Communication | 1 | 2015 | 69 | 0.490 |
Why?
| Mevalonic Acid | 1 | 2014 | 5 | 0.490 |
Why?
| Somatostatin-28 | 1 | 2014 | 3 | 0.480 |
Why?
| Receptors, Somatostatin | 1 | 2014 | 3 | 0.470 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2014 | 43 | 0.470 |
Why?
| Emulsions | 1 | 2014 | 24 | 0.470 |
Why?
| Calcium | 3 | 2014 | 396 | 0.460 |
Why?
| Enhancer Elements, Genetic | 3 | 2011 | 61 | 0.450 |
Why?
| Protein Engineering | 1 | 2013 | 18 | 0.450 |
Why?
| Endothelium, Vascular | 4 | 2010 | 252 | 0.450 |
Why?
| Gene Expression Regulation | 6 | 2015 | 976 | 0.440 |
Why?
| Escherichia coli | 2 | 2014 | 186 | 0.430 |
Why?
| Pancreas | 2 | 2011 | 70 | 0.430 |
Why?
| Osteogenesis | 2 | 2014 | 352 | 0.410 |
Why?
| Up-Regulation | 3 | 2015 | 452 | 0.400 |
Why?
| Osteoprotegerin | 3 | 2023 | 52 | 0.390 |
Why?
| Apoptosis | 4 | 2014 | 1101 | 0.390 |
Why?
| Radiation, Ionizing | 4 | 2022 | 100 | 0.380 |
Why?
| Mitochondria | 3 | 2024 | 402 | 0.370 |
Why?
| Thrombomodulin | 2 | 2008 | 27 | 0.330 |
Why?
| Disease Models, Animal | 2 | 2024 | 1455 | 0.330 |
Why?
| Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 34 | 0.300 |
Why?
| Transcription Factors | 2 | 2008 | 561 | 0.290 |
Why?
| Humans | 22 | 2024 | 49974 | 0.280 |
Why?
| Teriparatide | 1 | 2006 | 11 | 0.280 |
Why?
| Jejunum | 2 | 2021 | 54 | 0.270 |
Why?
| Mice, Knockout | 6 | 2022 | 841 | 0.270 |
Why?
| DNA-Binding Proteins | 1 | 2008 | 427 | 0.260 |
Why?
| Intestine, Small | 2 | 2021 | 109 | 0.250 |
Why?
| Hemiptera | 1 | 2024 | 4 | 0.250 |
Why?
| Membrane Transport Proteins | 2 | 2015 | 49 | 0.250 |
Why?
| Calorimetry, Differential Scanning | 1 | 2024 | 8 | 0.250 |
Why?
| Drug Stability | 1 | 2024 | 37 | 0.250 |
Why?
| Crassostrea | 1 | 2024 | 2 | 0.240 |
Why?
| Maleimides | 1 | 2024 | 8 | 0.240 |
Why?
| Biphenyl Compounds | 1 | 2024 | 31 | 0.240 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2024 | 38 | 0.240 |
Why?
| Rats | 4 | 2024 | 3305 | 0.240 |
Why?
| Heat-Shock Proteins | 2 | 2015 | 106 | 0.240 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2024 | 18 | 0.240 |
Why?
| Oxidative Stress | 5 | 2013 | 770 | 0.240 |
Why?
| Radiation Injuries | 4 | 2010 | 113 | 0.240 |
Why?
| Biocompatible Materials | 1 | 2024 | 69 | 0.240 |
Why?
| Ovary | 1 | 2024 | 104 | 0.230 |
Why?
| Umbilical Cord | 1 | 2024 | 35 | 0.230 |
Why?
| Testosterone | 1 | 2024 | 139 | 0.230 |
Why?
| Periosteum | 1 | 2024 | 26 | 0.230 |
Why?
| Lymphatic Vessels | 1 | 2024 | 48 | 0.230 |
Why?
| Osteolysis | 1 | 2024 | 75 | 0.230 |
Why?
| Cyclophosphamide | 1 | 2024 | 165 | 0.230 |
Why?
| Antihypertensive Agents | 1 | 2024 | 117 | 0.220 |
Why?
| Administration, Oral | 1 | 2024 | 426 | 0.220 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2003 | 51 | 0.220 |
Why?
| Cells, Cultured | 6 | 2017 | 1573 | 0.220 |
Why?
| Male | 19 | 2024 | 25241 | 0.220 |
Why?
| Glycoproteins | 2 | 2005 | 115 | 0.220 |
Why?
| Spine | 2 | 2022 | 94 | 0.220 |
Why?
| Osteomyelitis | 1 | 2024 | 126 | 0.210 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 64 | 0.210 |
Why?
| Protein Binding | 4 | 2014 | 660 | 0.210 |
Why?
| Lysosomal-Associated Membrane Protein 2 | 1 | 2022 | 4 | 0.210 |
Why?
| Energy Metabolism | 1 | 2024 | 282 | 0.200 |
Why?
| Female | 15 | 2024 | 26472 | 0.200 |
Why?
| Indoles | 1 | 2024 | 278 | 0.200 |
Why?
| Molecular Chaperones | 1 | 2022 | 64 | 0.200 |
Why?
| Duodenum | 1 | 2021 | 35 | 0.200 |
Why?
| Staphylococcal Infections | 1 | 2024 | 268 | 0.190 |
Why?
| Ileum | 1 | 2021 | 89 | 0.190 |
Why?
| Staphylococcus aureus | 1 | 2024 | 326 | 0.190 |
Why?
| Cyclic AMP | 2 | 2014 | 90 | 0.180 |
Why?
| Autophagy | 1 | 2022 | 169 | 0.180 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 61 | 0.180 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2019 | 22 | 0.170 |
Why?
| RNA, Messenger | 7 | 2013 | 1105 | 0.170 |
Why?
| Hyperparathyroidism | 2 | 2011 | 31 | 0.160 |
Why?
| Heptanoic Acids | 2 | 2008 | 34 | 0.160 |
Why?
| Pyrroles | 2 | 2008 | 69 | 0.160 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 4 | 2006 | 30 | 0.150 |
Why?
| Gene Expression | 4 | 2014 | 609 | 0.150 |
Why?
| Phenotype | 2 | 2024 | 729 | 0.150 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 142 | 0.150 |
Why?
| Bone Density | 4 | 2011 | 379 | 0.140 |
Why?
| Sepsis | 1 | 2019 | 220 | 0.140 |
Why?
| Immunity, Innate | 2 | 2024 | 104 | 0.140 |
Why?
| Chemokines | 2 | 2019 | 77 | 0.140 |
Why?
| Radiotherapy | 2 | 2007 | 128 | 0.130 |
Why?
| Ovariectomy | 2 | 2014 | 119 | 0.130 |
Why?
| NF-kappa B | 1 | 2017 | 314 | 0.130 |
Why?
| Blotting, Western | 2 | 2015 | 601 | 0.130 |
Why?
| Inflammation | 1 | 2019 | 604 | 0.130 |
Why?
| Microscopy, Electron, Transmission | 1 | 2015 | 75 | 0.130 |
Why?
| Microscopy, Confocal | 1 | 2015 | 88 | 0.130 |
Why?
| Transcription Factor CHOP | 1 | 2014 | 7 | 0.120 |
Why?
| Calmodulin | 1 | 2014 | 10 | 0.120 |
Why?
| Dose-Response Relationship, Radiation | 3 | 2010 | 184 | 0.120 |
Why?
| Fermentation | 1 | 2014 | 12 | 0.120 |
Why?
| Injections, Subcutaneous | 1 | 2014 | 54 | 0.120 |
Why?
| Half-Life | 1 | 2014 | 84 | 0.120 |
Why?
| Kinetics | 2 | 2014 | 623 | 0.120 |
Why?
| Phosphorylation | 2 | 2014 | 535 | 0.120 |
Why?
| Intestinal Diseases | 2 | 2019 | 25 | 0.120 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 108 | 0.110 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 83 | 0.110 |
Why?
| Natriuretic Peptide, Brain | 1 | 2014 | 29 | 0.110 |
Why?
| Polyethylene Glycols | 1 | 2014 | 93 | 0.110 |
Why?
| Ligands | 1 | 2014 | 204 | 0.110 |
Why?
| Mice, Inbred BALB C | 1 | 2014 | 304 | 0.110 |
Why?
| Protein Transport | 1 | 2014 | 180 | 0.110 |
Why?
| Homeostasis | 1 | 2014 | 200 | 0.110 |
Why?
| Nerve Fibers | 1 | 2013 | 11 | 0.110 |
Why?
| Lymphatic System | 1 | 2013 | 14 | 0.110 |
Why?
| Signal Transduction | 2 | 2014 | 1618 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 1376 | 0.110 |
Why?
| Immune System | 1 | 2013 | 44 | 0.110 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2014 | 349 | 0.110 |
Why?
| Cytokines | 2 | 2019 | 612 | 0.110 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2009 | 44 | 0.110 |
Why?
| Transfection | 1 | 2013 | 354 | 0.100 |
Why?
| Flow Cytometry | 1 | 2015 | 476 | 0.100 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.100 |
Why?
| Random Allocation | 2 | 2010 | 281 | 0.100 |
Why?
| Lactation | 1 | 2011 | 62 | 0.100 |
Why?
| Trypsin | 1 | 2011 | 12 | 0.100 |
Why?
| Skull | 3 | 2024 | 75 | 0.100 |
Why?
| Pentoxifylline | 1 | 2010 | 14 | 0.090 |
Why?
| Transcription, Genetic | 4 | 2010 | 369 | 0.090 |
Why?
| Lymph Nodes | 1 | 2013 | 260 | 0.090 |
Why?
| Hematopoiesis | 1 | 2010 | 71 | 0.090 |
Why?
| Cell Proliferation | 1 | 2014 | 1007 | 0.090 |
Why?
| Interferon-gamma | 1 | 2011 | 177 | 0.090 |
Why?
| Blood Vessels | 1 | 2010 | 72 | 0.090 |
Why?
| Base Sequence | 2 | 2014 | 643 | 0.090 |
Why?
| Radiation Dosage | 3 | 2021 | 157 | 0.090 |
Why?
| Molecular Sequence Data | 2 | 2014 | 792 | 0.090 |
Why?
| Leukocytes | 1 | 2010 | 66 | 0.090 |
Why?
| Cesium Radioisotopes | 1 | 2009 | 4 | 0.090 |
Why?
| Chemokine CXCL9 | 1 | 2009 | 7 | 0.090 |
Why?
| Thermoluminescent Dosimetry | 1 | 2009 | 7 | 0.090 |
Why?
| Bacterial Translocation | 1 | 2009 | 16 | 0.090 |
Why?
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 9 | 0.080 |
Why?
| Time Factors | 3 | 2011 | 2903 | 0.080 |
Why?
| Blood Cells | 1 | 2009 | 43 | 0.080 |
Why?
| Interleukin-12 | 1 | 2009 | 31 | 0.080 |
Why?
| Cerebellum | 1 | 2010 | 135 | 0.080 |
Why?
| Cell Lineage | 1 | 2009 | 83 | 0.080 |
Why?
| Femur | 2 | 2024 | 133 | 0.080 |
Why?
| rho-Associated Kinases | 1 | 2008 | 20 | 0.080 |
Why?
| Citrulline | 1 | 2009 | 95 | 0.080 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 6 | 0.080 |
Why?
| Brain Injuries | 1 | 2010 | 160 | 0.080 |
Why?
| Sp1 Transcription Factor | 1 | 2008 | 21 | 0.080 |
Why?
| 14-3-3 Proteins | 1 | 2008 | 18 | 0.080 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 391 | 0.080 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2008 | 36 | 0.080 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2008 | 50 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 466 | 0.080 |
Why?
| MAP Kinase Signaling System | 1 | 2008 | 119 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 99 | 0.070 |
Why?
| Peroxynitrous Acid | 3 | 2013 | 32 | 0.070 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 27 | 0.070 |
Why?
| Simvastatin | 1 | 2007 | 29 | 0.070 |
Why?
| Tissue Plasminogen Activator | 1 | 2008 | 109 | 0.070 |
Why?
| Connective Tissue | 1 | 2006 | 22 | 0.070 |
Why?
| Transcription Initiation Site | 1 | 2006 | 13 | 0.070 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 204 | 0.070 |
Why?
| Base Pairing | 1 | 2006 | 27 | 0.070 |
Why?
| Conserved Sequence | 1 | 2006 | 56 | 0.070 |
Why?
| Gene Deletion | 1 | 2007 | 266 | 0.070 |
Why?
| C-Reactive Protein | 1 | 2007 | 142 | 0.070 |
Why?
| Organ Specificity | 1 | 2006 | 108 | 0.070 |
Why?
| Cattle | 1 | 2006 | 210 | 0.070 |
Why?
| Binding Sites | 1 | 2006 | 374 | 0.060 |
Why?
| Wound Healing | 1 | 2006 | 204 | 0.060 |
Why?
| Bone Morphogenetic Proteins | 1 | 2005 | 56 | 0.060 |
Why?
| Organ Size | 2 | 2022 | 226 | 0.060 |
Why?
| Plant Diseases | 1 | 2024 | 8 | 0.060 |
Why?
| Vascular Endothelial Growth Factor C | 1 | 2024 | 4 | 0.060 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2024 | 5 | 0.060 |
Why?
| Aquaculture | 1 | 2024 | 4 | 0.060 |
Why?
| Phytoplankton | 1 | 2024 | 19 | 0.060 |
Why?
| Diatoms | 1 | 2024 | 20 | 0.060 |
Why?
| Titanium | 1 | 2024 | 48 | 0.060 |
Why?
| Immunomodulation | 1 | 2024 | 37 | 0.060 |
Why?
| Carcinoma, Transitional Cell | 1 | 2004 | 52 | 0.060 |
Why?
| Seasons | 1 | 2024 | 81 | 0.060 |
Why?
| Chondrocytes | 1 | 2024 | 41 | 0.060 |
Why?
| Reproduction | 1 | 2024 | 61 | 0.060 |
Why?
| Virulence | 1 | 2024 | 173 | 0.060 |
Why?
| Interleukin-6 | 1 | 2005 | 264 | 0.060 |
Why?
| Multienzyme Complexes | 1 | 2003 | 34 | 0.060 |
Why?
| Single-Cell Analysis | 1 | 2024 | 57 | 0.060 |
Why?
| Skin | 1 | 2006 | 409 | 0.060 |
Why?
| Metabolomics | 1 | 2024 | 126 | 0.060 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.060 |
Why?
| Liver | 1 | 2009 | 1115 | 0.060 |
Why?
| Bone and Bones | 2 | 2007 | 469 | 0.050 |
Why?
| Urinary Bladder Neoplasms | 1 | 2004 | 155 | 0.050 |
Why?
| Estrenes | 1 | 2002 | 13 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 36 | 0.050 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 225 | 0.050 |
Why?
| Genomics | 1 | 2024 | 286 | 0.050 |
Why?
| Transcription Factor AP-1 | 1 | 2002 | 63 | 0.050 |
Why?
| Transcriptome | 1 | 2024 | 315 | 0.050 |
Why?
| Cell Respiration | 1 | 2022 | 41 | 0.050 |
Why?
| Calcification, Physiologic | 1 | 2022 | 41 | 0.050 |
Why?
| Sirtuin 3 | 1 | 2022 | 19 | 0.050 |
Why?
| Primates | 1 | 2021 | 20 | 0.050 |
Why?
| Proteomics | 1 | 2024 | 329 | 0.050 |
Why?
| Treatment Outcome | 2 | 2009 | 5141 | 0.050 |
Why?
| Macaca mulatta | 1 | 2021 | 93 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 322 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 595 | 0.050 |
Why?
| Nitric Oxide Synthase | 2 | 2010 | 75 | 0.050 |
Why?
| Aging | 1 | 2024 | 687 | 0.040 |
Why?
| Molecular Structure | 1 | 2020 | 297 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2020 | 395 | 0.040 |
Why?
| Mice, Transgenic | 2 | 2013 | 555 | 0.040 |
Why?
| Endothelial Cells | 2 | 2010 | 269 | 0.040 |
Why?
| Neoplasms | 1 | 2006 | 1235 | 0.030 |
Why?
| Fibroblasts | 2 | 2009 | 345 | 0.030 |
Why?
| Models, Biological | 2 | 2013 | 727 | 0.030 |
Why?
| Receptors, Atrial Natriuretic Factor | 1 | 2014 | 8 | 0.030 |
Why?
| Cyclic GMP | 1 | 2014 | 20 | 0.030 |
Why?
| Gene Order | 1 | 2013 | 13 | 0.030 |
Why?
| Protein Conformation | 1 | 2014 | 166 | 0.030 |
Why?
| Cell Division | 2 | 2005 | 292 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 70 | 0.030 |
Why?
| Gene Targeting | 1 | 2013 | 29 | 0.030 |
Why?
| Nerve Endings | 1 | 2013 | 2 | 0.030 |
Why?
| Sympathetic Nervous System | 1 | 2013 | 20 | 0.030 |
Why?
| Neurotransmitter Agents | 1 | 2013 | 34 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2011 | 38 | 0.030 |
Why?
| Glutathione | 1 | 2013 | 295 | 0.030 |
Why?
| GTP Cyclohydrolase | 1 | 2010 | 4 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2010 | 23 | 0.020 |
Why?
| Drug Synergism | 1 | 2010 | 150 | 0.020 |
Why?
| Vascular System Injuries | 1 | 2010 | 36 | 0.020 |
Why?
| Vesicular Glutamate Transport Protein 2 | 1 | 2010 | 6 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 32 | 0.020 |
Why?
| Malondialdehyde | 1 | 2010 | 51 | 0.020 |
Why?
| Deoxyguanosine | 1 | 2010 | 27 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2010 | 191 | 0.020 |
Why?
| Core Binding Factor beta Subunit | 1 | 2009 | 3 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2010 | 151 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2009 | 66 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 73 | 0.020 |
Why?
| Survival Analysis | 1 | 2010 | 653 | 0.020 |
Why?
| Immunoblotting | 1 | 2009 | 118 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 562 | 0.020 |
Why?
| Stromal Cells | 1 | 2009 | 72 | 0.020 |
Why?
| Microarray Analysis | 1 | 2008 | 73 | 0.020 |
Why?
| Muscle, Smooth | 1 | 2008 | 63 | 0.020 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2010 | 202 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2009 | 215 | 0.020 |
Why?
| Vitamin D | 1 | 2009 | 88 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 21 | 0.020 |
Why?
| Receptors, Thrombin | 1 | 2007 | 11 | 0.020 |
Why?
| Survival Rate | 1 | 2010 | 894 | 0.020 |
Why?
| Thrombin | 1 | 2007 | 38 | 0.020 |
Why?
| Protein C | 1 | 2007 | 18 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2008 | 585 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2008 | 453 | 0.020 |
Why?
| Abdominal Neoplasms | 1 | 2007 | 16 | 0.020 |
Why?
| Pelvic Neoplasms | 1 | 2007 | 14 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 2007 | 144 | 0.020 |
Why?
| Lung | 1 | 2010 | 486 | 0.020 |
Why?
| Gastrointestinal Tract | 1 | 2007 | 103 | 0.020 |
Why?
| Injections | 1 | 2005 | 55 | 0.020 |
Why?
| Histocytochemistry | 1 | 2005 | 44 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 109 | 0.020 |
Why?
| Genetic Markers | 1 | 2005 | 102 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 104 | 0.020 |
Why?
| Absorptiometry, Photon | 1 | 2005 | 154 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2005 | 376 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 2004 | 90 | 0.020 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2004 | 86 | 0.020 |
Why?
| Lumbar Vertebrae | 1 | 2005 | 98 | 0.010 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 197 | 0.010 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 22 | 0.010 |
Why?
| Incidence | 1 | 2007 | 1003 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 48 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2008 | 1032 | 0.010 |
Why?
| Down-Regulation | 1 | 2004 | 348 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 170 | 0.010 |
Why?
| Compressive Strength | 1 | 2002 | 12 | 0.010 |
Why?
| Dihydrotestosterone | 1 | 2002 | 12 | 0.010 |
Why?
| HeLa Cells | 1 | 2003 | 250 | 0.010 |
Why?
| Seminal Vesicles | 1 | 2002 | 13 | 0.010 |
Why?
| Orchiectomy | 1 | 2002 | 41 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 114 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 129 | 0.010 |
Why?
| Osteocalcin | 1 | 2002 | 43 | 0.010 |
Why?
| RNA | 1 | 2003 | 170 | 0.010 |
Why?
| Uterus | 1 | 2002 | 94 | 0.010 |
Why?
| Receptors, Estrogen | 1 | 2002 | 130 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2002 | 465 | 0.010 |
Why?
| Pyrazoles | 1 | 2002 | 113 | 0.010 |
Why?
| Estradiol | 1 | 2002 | 225 | 0.010 |
Why?
| Osteoporosis | 1 | 2002 | 146 | 0.010 |
Why?
| Quality of Life | 1 | 2007 | 836 | 0.010 |
Why?
| Adenocarcinoma | 1 | 2004 | 396 | 0.010 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 828 | 0.010 |
Why?
| Body Weight | 1 | 2002 | 513 | 0.010 |
Why?
| Postoperative Complications | 1 | 2006 | 984 | 0.010 |
Why?
| Risk Factors | 1 | 2006 | 3613 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2004 | 3129 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2002 | 1174 | 0.010 |
Why?
| Aged | 1 | 2004 | 9310 | 0.010 |
Why?
| Middle Aged | 1 | 2004 | 12069 | 0.010 |
Why?
| Adult | 1 | 2004 | 13236 | 0.010 |
Why?
|
|
Fu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|